• KSCN
  • KSPAD
  • KSND
  • Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Articles

Page Path

Erratum

Correction of dosage of the drug: Post-infectious basal ganglia encephalitis and axonal variant of Guillain-Barré syndrome after COVID-19 infection: an atypical case report

Annals of Clinical Neurophysiology 2023;25(1):54-54.
Published online: April 28, 2023

Department of Neurology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea

Copyright © 2023 The Korean Society of Clinical Neurophysiology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 1,744 Views
  • 42 Download
prev
In published article by Yang et al., the dosage of intravenous immunoglobulin has been incorrectly spelled as 0.4 mg/kg/day. The correct dosage is 0.4 g/kg/day.
We apologize for any inconvenience caused.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      Correction of dosage of the drug: Post-infectious basal ganglia encephalitis and axonal variant of Guillain-Barré syndrome after COVID-19 infection: an atypical case report
      Ann Clin Neurophysiol. 2023;25(1):54-54.   Published online April 28, 2023
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Correction of dosage of the drug: Post-infectious basal ganglia encephalitis and axonal variant of Guillain-Barré syndrome after COVID-19 infection: an atypical case report
      Ann Clin Neurophysiol. 2023;25(1):54-54.   Published online April 28, 2023
      Close
      Correction of dosage of the drug: Post-infectious basal ganglia encephalitis and axonal variant of Guillain-Barré syndrome after COVID-19 infection: an atypical case report
      Correction of dosage of the drug: Post-infectious basal ganglia encephalitis and axonal variant of Guillain-Barré syndrome after COVID-19 infection: an atypical case report
      TOP